Tansy :

Tansy an emergency contraception is made up of a synthetic progesterone called levonorgestrel (1.5 mg levonorgestrel containing one tablet and 0.75 mg levonorgestrel containing two tablets). Tansy is being produced for the first time under the license of CHEMO Company in the Atipharmed International Pharmacy Company of Iran.

Advantages:

  • First hormonal pharmaceutical company in Iran that has been received GMP license.
  • produced by transferring European technology and based on the highest international standards, which ensures its effectiveness and safety.
  • Exclusively packaged by the best blister technology

Mechanism of action:

  • ovulation inhibition.
  • changes in the cervical mucus that inhibit sperm penetration.
  • effects on the endometrium that affect implantation.

 

Indications:

Emergency contraception, if:

 

  • contraceptive methods are not used during intercourse
  • Prevention methods are not used properly

 

Tansy should be taken according to the order of the doctor or pharmacist. If unprotected intercourse is less than 12 hours, you should receive a 0.75 mg tablet and then receive the next 0.75 mg tablet 12 hours later with water, but if unprotected intercourse occur more than 12 hours, you can take both 0.75mg tablet at the same time or take one 1.5 mg tansy with water. During breastfeeding, the medicine should be given immediately after milking. The milk is then taken and thrown away for 6 hours by the breast pump.

 

Contraindication:

  • history of thrombosis
  • active acute porphyria
  • current severe liver disease
  • focal migraine at the time of presentation

 


Levitude

Levitude is a combined oral contraceptive that consists of a progesterone called levonorgestrel and an estrogenic component called ethinyl estradiol. The drug is a second-generation contraceptive pill. Levitude is being produced for the first time under the license of CHEMO Company in the Atipharmed International Pharmacy Company of Iran.

Advantages:

  • First hormonal pharmaceutical company in Iran that has been received GMP license.
  • produced by transferring European technology and based on the highest international standards, which ensures its effectiveness and safety.
  • Exclusively packaged by the best blister technology
  • Levitude is the first and only LD contraceptive pill that contains 7 pills of white and placebo without hormone.
  • The efficacy of combined contraceptive pills with a consistent and consequent use is 99.9%, which in case of mistake due to the forgetting of commonly used pills, can be reduced to 91%, but Levitude Due to the presence of 7 placebo pills and the guide for the use of the drug, it provides the consumer with the highest level of efficacy.

 

  • Mechanism of action:
  • inhibits the secretion of pituitary gonadotropins.
  • ovulation inhibition.
  • changes in the cervical mucus that inhibit sperm penetration.
  • effects on the endometrium that prevent implantation.

 

Indications:

  • Contraception
    • Regulate menstruation cycles
    • Reduce the frequency of menstrual pain (dysmenorrhea)
    • Reduce severe and prolonged menstrual bleeding (menorrhagia).
    • Endometriosis treatment
    • Treatment of benign fibrocystic breast disease
    • Decreased ovarian cysts

Instruction:

Each Levitude blister contains 21 pills of yellow (containing hormone) and 7 pills of white (placebo) (without hormone). Each blister contains 28 pills, with two different pill sizes arranged in sequence. Levitude is given daily basis at a given time (every 24 hours) with or without food. After taking the seventh white tablet, the next pack of the next tablet will begin, whether the bleeding has been discontinued or not. Even with the use of 7 white blood hormone-free pills, protection against pregnancy will be achieved, but it is necessary to use another contraceptive method during the first 7 days of the first course of drug use.

 

Contraindication:

  • history of thrombosis
  • active acute porphyria
  • current severe liver disease
  • focal migraine at the time of presentation